DVLA logo

Darya-Varia Laboratoria Stock Price

Symbol: IDX:DVLAMarket Cap: Rp1.9tCategory: Pharmaceuticals & Biotech

DVLA Share Price Performance

DVLA Community Fair Values

    Recent DVLA News & Updates

    No updates

    PT Darya-Varia Laboratoria Tbk Key Details

    Rp2.1t

    Revenue

    Rp962.0b

    Cost of Revenue

    Rp1.1t

    Gross Profit

    Rp966.2b

    Other Expenses

    Rp158.2b

    Earnings

    Last Reported Earnings
    Jun 30, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    141.28
    Gross Margin
    53.89%
    Net Profit Margin
    7.58%
    Debt/Equity Ratio
    0%

    PT Darya-Varia Laboratoria Tbk Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About DVLA

    Founded
    1976
    Employees
    1295
    CEO
    n/a
    WebsiteView website
    www.darya-varia.com

    PT Darya-Varia Laboratoria Tbk manufactures and trades pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company offers prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems. It also provides Consumer Health products comprising Skin Nutrition under the Natur-E brand; Respiratory products under the Decolgen, ALLERIN EXPECTORANT, Decolsin, NEOZEP, STOP COLD, SILEX, and HERBABLEND brand names for nasal congestion, cough, as well as breathing issues caused by allergy; multivitamins under the Enervon-C, Enervon Active, Enervon Gold, and Supertin brands; vitamin C under the Vicee brand; and supplement for kids with Zinc and vitamin C under the Imunped brand; Biogesic for various types of pain; Diatabs, a anti diarrhea product; and New Enzyplex to prevent indigestion. In addition, the company offers toll manufacturing services for soft gelatin capsules, and sterile injections and low volume solid products. It also exports its products. PT Darya-Varia Laboratoria Tbk was founded in 1976 and is headquartered in Jakarta, Indonesia. PT Darya-Varia Laboratoria Tbk is a subsidiary of Blue Sphere Singapore Pte. Ltd.

    Indonesian Market Performance

    • 7 Days: 0.6%
    • 3 Months: 13.0%
    • 1 Year: 5.8%
    • Year to Date: 7.7%
    Over the last 7 days, the market has remained flat, although notably the Consumer Discretionary sector gained 3.6% in that time. More promisingly, the market is up 5.8% over the past year. As for the next few years, earnings are expected to grow by 7.9% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading